Detalles de la búsqueda
1.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood
; 137(19): 2646-2656, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512419
2.
Clinical and imaging features of myeloid sarcoma: a German multicenter study.
BMC Cancer
; 19(1): 1150, 2019 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31775680
3.
Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
Cancer
; 123(4): 638-649, 2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27763687
4.
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Ann Hematol
; 96(6): 887-894, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28374162
5.
New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes.
Genes Chromosomes Cancer
; 54(12): 717-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26394808
6.
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
Genes Chromosomes Cancer
; 54(12): 809-17, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26355708
7.
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.
Haematologica
; 100(2): 205-13, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344522
8.
Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin.
Cancers (Basel)
; 16(2)2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38254817
9.
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial.
Lancet Haematol
; 11(3): e196-e205, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301670
10.
Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes.
Am J Hematol
; 93(6): E152-E154, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29575088
11.
Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis.
J Cancer Res Clin Oncol
; 149(16): 14775-14784, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592032
12.
Cytogenetic peripheral blood monitoring in azacitidine treated patients with high-risk MDS/sAML: A monocentric real-world experience.
Leuk Res
; 124: 106996, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36538857
13.
Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology.
J Pers Med
; 13(12)2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38138928
14.
Predictors of lower exercise capacity in patients with cancer.
Sci Rep
; 13(1): 14861, 2023 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684302
15.
Cardiovascular and metabolic determinants of quality of life in patients with cancer.
ESC Heart Fail
; 10(1): 167-176, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178215
16.
Optimizing the structure of interdisciplinary tumor boards for effective cancer care.
Front Oncol
; 13: 1072652, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182140
17.
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project.
J Cancer Res Clin Oncol
; 149(11): 8829-8842, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37145199
18.
Therapy-related myeloid neoplasms following treatment with radioiodine.
Haematologica
; 97(2): 206-12, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21993688
19.
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.
Hemasphere
; 6(12): e808, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479544
20.
Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients.
Ther Drug Monit
; 33(5): 632-43, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21912334